Session Details
[2S01e]TBA
Thu. Nov 7, 2024 4:50 PM - 6:50 PM JST
Thu. Nov 7, 2024 7:50 AM - 9:50 AM UTC
Thu. Nov 7, 2024 7:50 AM - 9:50 AM UTC
Room1(G303+304)
Organizers:Toshiro Sato(Keio University), Takanori Takebe(Osaka University)
共催:日本医療研究開発機構 革新的先端研究開発支援事業(AMED-CREST/PRIME)「適応・修復」研究開発領域
[2S01e-01]Liver injury model using a liver organoid associated with the biliary system
○Naoki Tanimizu, Kenji Aoshima, Ayumi Okumura (Institute of Medical Science, The University of Tokyo)
キーテクノロジー:Organoid
[2S01e-02]Establishment of human adult hepatocyte organoids with long-term expansion and functional capacities
○Ryo Igarashi, Toshiro Sato (Department of Integrated Medicine and Biochemistry, Keio University School of Medicine)
キーテクノロジー:オルガノイド
[2S01e-03]Conversion of hepatocytes into intestinal epithelial cells
○Shizuka Miura, Kenichi Horisawa, Satsuki Karasawa, Atsushi Suzuki (Medical Institute of Bioregulation, Kyushu University)
キーテクノロジー:リプログラミング
[2S01e-04]Development of a bioartificial liver supporting device implanted with human liver organoids for ACLF treatment
○Yosuke Yoneyama1,2, Hitomi Yamaguchi2, Takanori Takebe1,2,3 (1.Graduate School of Medicine, Osaka University, 2.Institute of Research, Tokyo Medical and Dental University, 3.Cincinnati Children’s Hospital Medical Center)
キーテクノロジー:オルガノイド
[2S01e-05]Innovation of hepatobiliary organoid development for pharmaceutical research use
○Minoru Tanaka (National Center for Global Health and Medicine)
キーテクノロジー:Organoid culture